For full dosage and administration information, please see the Fact Sheet for Healthcare Providers.
Bamlanivimab injection (700 mg/20 mL)
Bamlanivimab is a sterile, preservative-free solution available as:
- Injection: 700 mg/20 mL (35 mg/mL) in a single-dose vial.
The dosage of bamlanivimab in adults and pediatric patients (12 years of age and older weighing at least 40g) is bamlanivimab 700 mg.
No dosage adjustment is recommended in pediatric patients who weigh at least 40 kg and are 12 years of age and older. Bamlanivimab is not authorized for patients weighing less than 40kg or those less than 12 years of age.
Administer bamlanivimab as soon as possible after positive results of direct SARS-CoV-2 viral testing and within 10 days of symptom onset.
Bamlanivimab must be diluted and administered as a single IV infusion over at least 60 minutes.
Recommended dilution and administration instructions for bamlanivimab
|Drug||Number of Vials||Volume of Bamlanivimab||Volume of 0.9% Sodium Chloride||Total Volume for Infusion||Maximum Infusion Rate||Minimum Infusion Time|
|Bamlanivimab (700 mg/20 mL)||Number of Vials: 1 Vial||Volume of Bamlanivimab: 20 mL||Volume of 0.9% Sodium Chloride: 250 mL||Total Volume for Infusion: 270 mL||Maximum Infusion Rate: 270 mL/hr||Minimum Infusion Time: 60 Minutes|
State, territorial, and local public health officials along with individual sites of care looking for assistance with operationalizing the administration of bamlanivimab may view the Bamlanivimab Antibody Playbook.
These short videos show a brief representation of the process to prepare the IV infusion of bamlanivimab and the administration of a prepared IV infusion. For further details regarding bamlanivimab as a treatment, please review the Fact Sheet for Healthcare Providers available on this website. These videos are not training videos and are for demonstration purposes only.